Mansanades, Juliet J.
HRN: 22-77-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/23/2023
CLINDAMYCIN 300MG (CAP)
03/23/2023
03/29/2023
ORAL
300 Mg
Q6
Open Wound At Left Breast
Waiting Final Action
Indication: Empirical De-escalation Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes